Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy
Abnormal structural and molecular changes in malignant tissues were thoroughly investigated and utilized to target tumor cells, hence rescuing normal healthy tissues and lowering the unwanted side effects as non-specific cytotoxicity. Various ligands for cancer cell specific markers have been uncove...
Enregistré dans:
Auteurs principaux: | Layla Al-mansoori, Philip Elsinga, Sayed K. Goda |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/02c94a827e154a48a2cc15bc82004766 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types
par: Nagarjun Kasaraneni, et autres
Publié: (2017) -
Cancer Patient Tissueoid with Self‐Homing Nano‐Targeting of Metabolic Inhibitor
par: Hyo‐Jin Yoon, et autres
Publié: (2021) -
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
par: Shengnan Bao, et autres
Publié: (2021) -
Lymphadenopathy after the third Covid-19 vaccine
par: Can Özütemiz, et autres
Publié: (2021) -
Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy
par: Oyeon Cho, et autres
Publié: (2021)